Oncolife HRR 15 Gene (Germline+Somatic)
Test Name
Oncolife HRR 15 Gene (Germline+Somatic)
Home Collection, Lab Visit
Test Code
ONCO0067
Test Components/ Genes/ Parameters
ATM, BARD1, BRCA1, BRCA2, BRIP1, CDK12,CHEK1, CHEK2,FANCL, PALB2,PPP2R2A, RAD51B,RAD51C, RAD51D, RAD54L
Sample Report
Click on Icon
Test Information
TAT DETAILS
21 days
PRE-TEST INSTRUCTIONS
Submit formalin fixed paraffin embedded Tissue Block. Ship at room temperature OR 4 mL (2 mL min.) Whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. Duly filled BRCA 1 & 2 informed consent form for hereditary testing (Form 24) is mandatory.
CLINICAL UTILITY
Offers important value addition to the patient by identifying mutations in 15 genes which are predictive biomarkers for PARP inhibitor therapy.
SPECIMEN STABILITY
Transport at ambient (18-25°C) temperature
METHODOLOGY
NGS
STORAGE TEMPERATURE
NA
SPECIMEN TYPE
Surgical tissue/Tissue Block
Frequently Asked Questions
Oncolife HRR 15 Gene (Germline+Somatic)
Offers important value addition to the patient by identifying mutations in 15 genes which are predictive biomarkers for PARP inhibitor therapy.
The patient should carry the FFPE tissue or block of the effected Breast. This process is carried out by Breast Surgeon in the hospital
The test is recommended when there is a family history of Breast & Prostate Cancer
The test is performed with the Next generation sequencing technique
There is no risk associated with the test as biopsy will be taken by the trained surgeon in the hospital under anasthesia
Result is reported as Pathogenic/No pathogenic or likely pathogenic variants causative of the reported phenotype were identified. Correlation with clinical profile and family history is required